DP

Dr. Ping Cao

Founder & CEO

BridGene Biosciences

BridGene Biosciences Pipeline

DrugIndicationPhase
Undisclosed Oncology ProgramsOncology (e.g., targeting transcription factors)Discovery/Preclinical
Undisclosed Neurology ProgramsNeurological DisordersDiscovery
Undisclosed Immunology ProgramsImmunological DisordersDiscovery